{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:39:30Z","timestamp":1784702370273,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020721","name":"University of Lagos","doi-asserted-by":"publisher","award":["2019\/08"],"award-info":[{"award-number":["2019\/08"]}],"id":[{"id":"10.13039\/501100020721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.schres.2025.03.005","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T16:20:35Z","timestamp":1741710035000},"page":"171-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dopamine receptor D2 (DRD2) TaqIA gene polymorphism and acute risperidone-induced changes in body weight, plasma glucose and lipid profile"],"prefix":"10.1016","volume":"277","author":[{"given":"Holiness S.A.","family":"Olasore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph O.","family":"Faleti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwo O.","family":"Afe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullahi A.","family":"Murtala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew O.","family":"Olawale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur-Rasheed B.","family":"Awesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam N.","family":"Igwo-Ezikpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubunmi A.","family":"Magbagbeola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Olashore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0005","article-title":"The pathways to the first contact with mental health services among patients with schizophrenia in Lagos, Nigeria","volume":"2013","author":"Adeosun","year":"2013","journal-title":"Schizophrenia research and treatment"},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/0976-3147.178652","article-title":"Perception of service satisfaction and quality of life of patients living with schizophrenia in Lagos, Nigeria","volume":"7","author":"Afe","year":"2016","journal-title":"Journal of Neurosciences in Rural Practice"},{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/npmj.npmj_93_19","article-title":"Antipsychotic prescription and polypharmacy among outpatients with schizophrenia in a Nigerian hospital","volume":"27","author":"Anozie","year":"2020","journal-title":"Nigerian Postgraduate Medical Journal"},{"issue":"11\u221212","key":"10.1016\/j.schres.2025.03.005_bb0020","doi-asserted-by":"crossref","first-page":"1900044","DOI":"10.1002\/minf.201900044","article-title":"Probing binding landscapes and molecular recognition mechanisms of atypical antipsychotic drugs towards the selective targeting of D2 dopamine receptor","volume":"38","author":"Appiah-Kubi","year":"2019","journal-title":"Mol. Inf."},{"issue":"11","key":"10.1016\/j.schres.2025.03.005_bb0025","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ebiom.2015.10.018","article-title":"Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure","volume":"2","author":"Bahr","year":"2015","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.schres.2025.03.005_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025537","article-title":"Dopamine receptors in human adipocytes: expression and functions","volume":"6","author":"Borcherding","year":"2011","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.schres.2025.03.005_bb0035","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1463-1326.2006.00671.x","article-title":"Adipocyte prolactin: regulation of release and putative functions","volume":"9","author":"Brandebourg","year":"2007","journal-title":"Diabetes. Obes. Metab."},{"key":"10.1016\/j.schres.2025.03.005_bb0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40261-019-00751-2","article-title":"Association of first-vs. second-generation antipsychotics with lipid abnormalities in individuals with severe mental illness: a systematic review and meta-analysis","volume":"39","author":"Buhagiar","year":"2019","journal-title":"Clin. Drug Investig."},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12470","article-title":"Taq1a polymorphism (rs1800497) is associated with obesity-related outcomes and dietary intake in a multi-ethnic sample of children","volume":"14","author":"Cardel","year":"2019","journal-title":"Pediatr. Obes."},{"issue":"3","key":"10.1016\/j.schres.2025.03.005_bb0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.physbeh.2008.11.011","article-title":"Risperidone alters food intake, core body temperature, and locomotor activity in mice","volume":"96","author":"Cope","year":"2009","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/j.2051-5545.2009.tb00199.x","article-title":"Metabolic syndrome in people with schizophrenia: a review","volume":"8","author":"De Hert","year":"2009","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2025.03.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-024-02531-7","article-title":"Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor","author":"Gaitonde","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"7273","key":"10.1016\/j.schres.2025.03.005_bb0065","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"321","author":"Geddes","year":"2000","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0070","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5812\/ijem.3505","article-title":"Normality tests for statistical analysis: a guide for non-statisticians","volume":"10","author":"Ghasemi","year":"2012","journal-title":"International journal of endocrinology and metabolism"},{"issue":"10","key":"10.1016\/j.schres.2025.03.005_bb0080","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.euroneuro.2017.07.001","article-title":"International trends in antipsychotic use: a study in 16 countries, 2005\u20132014","volume":"27","author":"H\u00e1lfd\u00e1narson","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2025.03.005_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-015-1146-z","article-title":"Gender differences in the use of psychiatric outpatient specialist services in Troms\u00f8, Norway are dependent on age: a population-based cross-sectional survey","volume":"15","author":"Hansen","year":"2015","journal-title":"BMC Health Serv. Res."},{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12991-022-00412-3","article-title":"Gender differences in psychiatric outpatients: a before and during COVID-19 pandemic study in general hospitals from China","volume":"21","author":"He","year":"2022","journal-title":"Ann. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2025.03.005_bb0095","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3390\/ijms18102174","article-title":"Unresolved issues for utilization of atypical antipsychotics in schizophrenia: antipsychotic polypharmacy and metabolic syndrome","volume":"18","author":"Jeon","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.schres.2025.03.005_bb0100","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/ijms21072516","article-title":"Ankyrin repeat and kinase domain containing 1 gene, and addiction vulnerability","volume":"21","author":"Koeneke","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.schres.2025.03.005_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1297-9686-41-15","article-title":"Detecting selection-induced departures from Hardy-Weinberg proportions","volume":"41","author":"Lachance","year":"2009","journal-title":"Genet. Sel. Evol."},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.jcp.0000203196.65710.2b","article-title":"Risperidone-related weight gain: genetic and nongenetic predictors","volume":"26","author":"Lane","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2025.03.005_bb0115","first-page":"8","article-title":"Metabolic changes associated with antipsychotic use","volume":"6","author":"Lieberman","year":"2004","journal-title":"Primary care companion to the Journal of clinical psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2025.03.005_bb0120","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3390\/biomedicines11112993","article-title":"Dopamine in the regulation of glucose homeostasis, pathogenesis of type 2 diabetes, and chronic conditions of impaired dopamine activity\/metabolism: implication for pathophysiological and therapeutic purposes","volume":"11","author":"Lisco","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.schres.2025.03.005_bb0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fendo.2020.00152","article-title":"D2-like receptors mediate dopamine-inhibited insulin secretion via ion channels in rat pancreatic \u03b2-cells","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.schres.2025.03.005_bb0130","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/nu13030848","article-title":"A systematic review of genetic polymorphisms associated with binge eating disorder","volume":"13","author":"Manfredi","year":"2021","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.schres.2025.03.005_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ddr.21337","article-title":"Improving current treatments for schizophrenia","volume":"77","author":"Maric","year":"2016","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.schres.2025.03.005_bb0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajmg.1303","article-title":"Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol","volume":"105","author":"Mihara","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.schres.2025.03.005_bb0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jpsychires.2018.02.018","article-title":"DNA methylation of ANKK1 and response to aripiprazole in patients with acute schizophrenia: a preliminary study","volume":"100","author":"Miura","year":"2018","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/tpj.2010.65","article-title":"Systematic analysis of dopamine receptor genes (DRD1\u2013DRD5) in antipsychotic-induced weight gain","volume":"12","author":"M\u00fcller","year":"2012","journal-title":"Pharmacogenomics J."},{"issue":"5","key":"10.1016\/j.schres.2025.03.005_bb0155","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/life12050606","article-title":"Dopamine and dopamine-related ligands can bind not only to dopamine receptors","volume":"12","author":"Myslivecek","year":"2022","journal-title":"Life"},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0160","first-page":"187","article-title":"The essentiality of reporting Hardy-Weinberg equilibrium calculations in population-based genetic association studies","volume":"17","author":"Namipashaki","year":"2015","journal-title":"Cell Journal (Yakhteh)"},{"issue":"7","key":"10.1016\/j.schres.2025.03.005_bb0165","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.31557\/APJCP.2024.25.7.2229","article-title":"Hardy-Weinberg equilibrium in meta-analysis studies and large-scale genomic sequencing era","volume":"25","author":"Neamatzadeh","year":"2024","journal-title":"Asian Pacific journal of cancer prevention: APJCP"},{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12864-025-11321-6","article-title":"Gene-based Hardy-Weinberg equilibrium test using genotype count data identifies novel cancer-related genes","volume":"26","author":"Nishino","year":"2024","journal-title":"BMC genomics"},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/pchj.41","article-title":"Association of dopamine receptor D 2 TaqI A polymorphism and cannabis use disorder in Lagos, Nigeria","volume":"3","author":"Olasore","year":"2014","journal-title":"PsyCh Journal"},{"issue":"1\u20132","key":"10.1016\/j.schres.2025.03.005_bb0180","article-title":"Association of Plasma Dopamine and Norepinephrine Levels and Cannabis use among male Cannabis smokers","volume":"7","author":"Olasore","year":"2021","journal-title":"University of Lagos Journal of Basic Medical Sciences"},{"key":"10.1016\/j.schres.2025.03.005_bb0185","article-title":"Association of Dopamine Transporter Gene (DAT1) 40 bp 3\u2032 UTR VNTR polymorphism (rs28363170) and Cannabis use disorder","volume":"17","author":"Olasore","year":"2023","journal-title":"Substance Abuse: Research and Treatment"},{"key":"10.1016\/j.schres.2025.03.005_bb0190","doi-asserted-by":"crossref","DOI":"10.1177\/20503121241241922","article-title":"Association between dopamine receptor D2 Taq IA gene polymorphism (rs1800497) and personality traits","volume":"12","author":"Olasore","year":"2024","journal-title":"SAGE Open Med"},{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0195","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2025.03.005_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769744","article-title":"Effects of pituitary surgery and high-dose cabergoline therapy on metabolic profile in patients with prolactinoma resistant to conventional cabergoline treatment","volume":"12","author":"Pirchio","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.schres.2025.03.005_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1015520","article-title":"Metabolic effects of prolactin [review]","volume":"13","author":"Pirchio","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.17650\/2712-7672-2020-1-2-43-51","article-title":"Negative symptoms of schizophrenia: new prospects of Cariprazine treatment","volume":"1","author":"Reznik","year":"2020","journal-title":"Consortium Psychiatricum"},{"key":"10.1016\/j.schres.2025.03.005_bb0215","first-page":"835","article-title":"DRD2\/ANKK1 TaqI A1 polymorphism associates with overconsumption of unhealthy foods and biochemical abnormalities in a Mexican population","volume":"24","author":"Rivera-I\u00f1iguez","year":"2019","journal-title":"Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity"},{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0220","first-page":"1","article-title":"The importance of examining the Hardy-Weinberg equilibrium in genetic association studies","volume":"13","author":"Saadat","year":"2024","journal-title":"Molecular Biology Research Communications"},{"issue":"7","key":"10.1016\/j.schres.2025.03.005_bb0225","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4088\/JCP.08r04392","article-title":"Atypical antipsychotics dose dependent? A literature review","volume":"70","author":"Simon","year":"2009","journal-title":"J. Clin. Psych."},{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","article-title":"Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies","volume":"27","author":"Solmi","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2025.03.005_bb0235","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4088\/JCP.v62n0901","article-title":"\u201cHit-and-run\u201d actions at dopamine receptors, part 1: mechanism of action of atypical antipsychotics","volume":"62","author":"Stahl","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2025.03.005_bb0240","first-page":"9","article-title":"Describing an atypical antipsychotic: receptor binding and its role in pathophysiology","volume":"5","author":"Stahl","year":"2003","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0245","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41467-017-00716-z","article-title":"Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors","volume":"8","author":"Sykes","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.schres.2025.03.005_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.713418","article-title":"Peripheral dopamine directly acts on insulin-sensitive tissues to regulate insulin signaling and metabolic function","volume":"12","author":"Tavares","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/syn.20468","article-title":"Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo \u03bcPET imaging ([11C] raclopride) and in-vitro ([3H] spiperone) autoradiography","volume":"62","author":"Thanos","year":"2008","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0260","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.psychres.2014.05.039","article-title":"Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine","volume":"219","author":"Tybura","year":"2014","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.schres.2025.03.005_bb0265","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.neuroimage.2008.06.002","article-title":"Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors","volume":"42","author":"Volkow","year":"2008","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.schres.2025.03.005_bb0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tics.2010.11.001","article-title":"Reward, dopamine and the control of food intake: implications for obesity","volume":"15","author":"Volkow","year":"2011","journal-title":"Trends Cogn. Sci."},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0275","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12020-023-03525-1","article-title":"Subcutaneous adipose tissue dopamine D2 receptor is increased in prediabetes and T2D","volume":"83","author":"Vranic","year":"2024","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.schres.2025.03.005_bb0280","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cns.13281","article-title":"Risperidone stimulates food intake and induces body weight gain via the hypothalamic arcuate nucleus 5-HT2c receptor\u2014NPY pathway","volume":"26","author":"Wan","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.schres.2025.03.005_bb0285","doi-asserted-by":"crossref","first-page":"1137977","DOI":"10.3389\/fmed.2023.1137977","article-title":"Influence of antipsychotic medications on hyperlipidemia risk in patients with schizophrenia: evidence from a population-based cohort study and in vitro hepatic lipid homeostasis gene expression","volume":"10","author":"Wu","year":"2023","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.schres.2025.03.005_bb0290","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1192\/bjp.185.2.147","article-title":"Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2* A1 allele","volume":"185","author":"Young","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2025.03.005_bb0295","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00228-019-02739-5","article-title":"Insulin resistance induced by olanzapine and other second-generation antipsychotics in Chinese patients with schizophrenia: a comparative review and meta-analysis","volume":"75","author":"Yu","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.schres.2025.03.005_bb0300","first-page":"235","article-title":"No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response","volume":"24","author":"Zhang","year":"2003","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425000672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425000672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:03:55Z","timestamp":1774530235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996425000672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":59,"alternative-id":["S0920996425000672"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2025.03.005","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine receptor D2 (DRD2) TaqIA gene polymorphism and acute risperidone-induced changes in body weight, plasma glucose and lipid profile","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2025.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}